1 / 78

Transfusion medicine

Transfusion medicine. A.Basi ADULT HEMATOLOGIST ,ONCOLOGIST IRAN UNIVERSITY OF MEDICAL SCIENCES. The standard donation is approximately 450 mL (within 10%) of blood collected into 63 mL of citrate phosphate dextrose anticoagulant, resulting in a final volume of 468 to 558 mL.

glain
Download Presentation

Transfusion medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transfusion medicine A.Basi ADULT HEMATOLOGIST ,ONCOLOGIST IRAN UNIVERSITY OF MEDICAL SCIENCES

  2. The standard donation is approximately 450 mL (within 10%) of blood collected into 63 mL of citrate phosphate dextrose anticoagulant, resulting in a final volume of 468 to 558 mL .

  3. Before being made available for transfusion, donated blood undergoes several tests involving red cell typing, antibody detection, and screening for transmissible diseases.

  4. ABO and Rh Typing • RBC typing is necessary so that the components can be labeled properly and selected for patients with appropriate ABO and Rh types. • Because of their clinical significance, these two blood groups are the only ones that are determined routinely.

  5. Blood Groups • Karl Landsteiner Nobel Prize in Physiology or Medicine in 1930

  6. Blood Groups • Blood Group systems: 1.major (ABO,Rh) 2.minor (100 systems with about 500 antigens)

  7. Red Blood Cell Blood Groups

  8. Blood Groups (Red cell Antigens) • Present on RBCs, GI tract and vascular endothelium • Specificity of the antigen is in its terminal sugar • galactosamine for A • galactose for B

  9. Selection by ABO type

  10. Rh system:D,d,C,c,e,e(Fisher-Race),Wiener

  11. Rh type • Rh blood group antigens are present only on RBCs • Rh positive means that the D antigen is present (85% on the population). • Rh negative means that the D antigen is absent (15% of the population). • the D antigen is highly immunogenic. • More than 80% of D negative persons receiving D positive blood are expected to develop anti-D.

  12. Rh Antibodies • The most common Rh antibody is anti-D. This is almost always an IgG, acts at 37ºC, and does not bind complement effectively. • but causes serious transfusion reactions and red cell destruction by accelerated clearance of cells through the mononuclear phagocyte system.

  13. Major Crossmatch (Compatibility testing) • Donor RBCs (unit of blood) are tested with recipient serum. • To detect unexpected recipient antibodies.

  14. Compatibility testing • ABO confirmation and Rh determination of the recipient's red cells. • ABO confirmation and Rh confirmation of the donor red cells if labeled as Rh negative. • Antibody screen of the donor serum to detect clinically significant antibodies. • Crossmatch of the recipient's serum with the donor red cells by a method which will detect ABO incompatibility and clinically significant antibodies.

  15. Blood Used on Emergency Basis • Blood used on Emergency Basis • for a patient that is bleeding out • and the blood type is unknown • Group O, Rh negative, uncrossmatched. • Recipient may have an unexpected antibody.

  16. Screening for transmissible diseases • Serologic Test for Syphilis • Hepatitis B Surface Antigen • Anti-HCV • Human Immunodeficiency Virus 1 and 2 Antibody • Human T-Cell Lymphotrophic Virus I and II Antibody

  17. Blood component WB PLT PRBC FFP

  18. Indication The availability of an adequate and safe supply of blood and its components is essential for: • Many surgical procedures, • Treatment of patients who experience acute or chronic blood loss, • Those with inadequate blood cellproduction, • Excessive destruction of their own blood cells, • Or an inherited defect of red cells or coagulation factors.

  19. Whole Blood • 450 ml of whole blood with 63 ml of anticoagulant • Need for oxygen carrying capacity and volume replacement • No viable platelets or WBC • Decreased labile coagulation factors (Factor V and VIII) • Not available since it is not efficient utilization of blood

  20. packed red cells or red cell concentrate • The commonly used red cell preservative solutions contain glucose, adenine, mannitol, and sodium chloride. • These preservative solutions allow storage of red cells for 42 days at 1º to 6ºC.

  21. packed red cells or red cell concentrate • Because red cell metabolism continues during storage, metabolites accumulate in stored red cell units and lead to biochemical changes. • Four of these changes are discussed: loss of ATP and viability, loss of DPG and function, accumulation of potassium, and hemolysis.

  22. Packed Red Blood Cells (PRBCs) • 200-250 ml of RBCs and 50 ml of plasma • Hematocrit 55-70% depending on anticoagulant • Shelf life 35 to 42 days depending on the anticoagulant • Treatment of symptomatic anemia where oxygen carrying capacity is needed

  23. Leukocyte Reduced RBCs • RBCs with 99.99% of WBCs removed by leukocyte reduction filter. • Prevents repeated nonhemolytic febrile transfusion reactions. • Prevents HLA class 1 alloimmunization. • Do not transmit cytomegalovirus infection • All cellular components are leukoreduced now.

  24. Indications for Leukocyte Reduced RBC continued • After second nonhemolytic febrile transfusion reaction. • Chronically transfused patients. • Potential transplant recipients. • CMV seronegative at-risk patients for whom seronegative components are not available.

  25. Frozen RBCs • Store RBCs for up to 10 years at -80C in 40% glycerol. • Glycerol is a cryopreservative solution • Used for: • Rare blood types for patients with multiple antibodies. • Autologous blood for a postponed operation. • Patients with IgA deficiency.

  26. Gamma Irradiated RBCs • RBCs and platelets are exposed to gamma irradiation at 2500 rads for 4.5 minutes. • This inactivates the T lymphocytes in the donor unit and prevents graft versus host disease in an immunocompromised recipient. • Reduced red cell viability and a leakage of potassium, decreasing the shelf life 28 days of total storage time.

  27. Indications for Gamma Irradiated RBCs • Bone marrow transplant recipients. • Congenital immunodeficiency syndromes. • Intrauterine transfusions. • Transfusions from all blood relatives.. • Neutropenic patient.

  28. Washed red cells The unit of blood can be washed immediately before infusion. • Patients with severe or recurrent allergic reactions (eg, hives) associated with red cell transfusion. • Certain patients with IgA deficiency when IgA deficient donors are not available. • In the rare patient with a complement-dependent autoimmune hemolytic anemia to prevent complement infusion.

  29. Fresh Frozen Plasma • FFP is the liquid portion of one unit of blood that has been centrifuged, separated, and frozen solid at -18ºC or colder within 6 hours of collection. • The unit of whole blood is usually centrifuged using techniques to prepare platelet-rich plasma This platelet-rich plasma is then centrifuged, and the plasma is removed and frozen, giving one unit of FFP and one unit of platelet concentrate.

  30. Fresh Frozen Plasma • FFP can be stored for up to 1 year at -18ºC or colder. • The unit of FFP has a volume of approximately 200mL and contains all the constituents of citrated normal plasma.

  31. Fresh Frozen Plasma (FFP) • 200-250 ml of plasma frozen at -18C within6- 8 hours of collection. • No platelets are present. • Contains all coagulation factors. • An unconcentrated source of fibrinogen. • use Cryo to correct a low fibrinogen level • Needs 20-30 min lead time to thaw prior to use.

  32. Indications for use of FFP • Replacement of isolated coagulation factor deficiencies when specific components are not available. Examples include factors V, VIII, IX, X, and XI. • Reversal of warfarin effect in patients actively bleeding or who require emergency surgery. • Antithrombin III deficiency in patients undergoing surgery or those who require heparin for treatment of thrombosis. • Treatment of thrombotic thrombocytopenic purpura (TTP), usually as part of plasma exchange.

  33. FFP Continued • Used in patients with multiple coagulation factor deficiencies: • liver disease • DIC • Massive transfusion (if plt<75000:plt transfusion) • Indicated when PT/PTT are >17/55 sec or>1.5 normal or fibrinogen level<100.

  34. Fresh Frozen Plasma • In an average-sized adult, five units of FFP would raise the level of coagulation factors approximately 30%, which is a level thought to provide hemostasis. • Because this would involve transfusion of approximately 1000 mL of plasma, the patient's blood volume and cardiovascular status must be considered.

  35. Cryoprecipitate • Cryoprecipitate is the material that remains insoluble when previously frozen plasma is thawed at 1º to 6ºC. • Each bag of cryoprecipitate contains approximately 100 U of factor VIII and 200-300 mg of fibrinogen,factor XIII, vwf and has a volume of approximately 10 mL. Thus, cryoprecipitate can be used to replace factor VIII or fibrinogen. • Cryoprecipitate can be stored for up to 1 year at -18ºC or lower.

  36. Random Donor Platelet Concentrates • A random donor platelet concentrate is prepared from a standard unit of whole blood. • Because cold temperatures damage platelets, the unit of whole blood is maintained at room temperature, and platelets are removed within 6 hours of collection.

  37. Random Donor Platelet Concentrates • Random donor platelet concentrates may be stored for up to 5 days at room temperature (20º to 24ºC).

  38. Random Donor Platelet Concentrates • Actually, satisfactory platelet function can be maintained for up to 7 days .but storage longer than 5 days allows bacterial proliferation in some concentrates . • This has been associated with transmission of infection.

  39. prophylactic platelet transfusion

  40. Single donor platelets (plateletpheresis) • Automated methods that permitted the collection of the equivalent of six to ten units of platelets (3 to 6 x 10(11) platelets) from normal donors in 1/5 to 2 hour procedure. • An individual can donate platelets as often as twice per week without becoming anemic or thrombocytopenic. • The clear advantage of single donor apheresis concentrates is reduced donor exposure.

More Related